Biogenic and Biomimetic Carriers as Versatile Transporters To Treat Infections.
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Your vote was cast
Thank you for your feedback
Thank you for your feedback
MetadataShow full item record
AbstractBiogenic and biomimetic therapeutics are a relatively new class of systems that are of physiological origin and/or take advantage of natural pathways or aim at mimicking these to improve selective interaction with target tissue. The number of biogenic and bioengineered avenues for drug therapy and diagnostics has multiplied over the past years for many applications, indicating the high expectations associated with this biological route. Nevertheless, the use of "bio"-related approaches for treating or diagnosing infectious diseases is still rare. Given that infectious diseases, in particular bacterial resistances, are seriously on the rise, there is an urgent need to take advantage of biogenic and bioengineered systems to target these challenges. In this manuscript, we first give a definition of the various "bio" terms, including biogenic, biomimetic, bioinspired, and bioengineered and we highlight them using tangible applications in the field of infectious diseases. Our examples cover cell-derived systems, including bioengineered bacteria, virus-like particles, and different cell-mimetics. Moreover, we discuss natural and bioengineered particles such as extracellular vesicles from mammalian and bacterial sources and liposomes. A concluding section outlines the potential for biomaterial-related avenues to overcome challenges associated with difficult-to-treat infections. We critically discuss benefits and risks for these applications and give an outlook on the future of biogenic engineering.
CitationACS Infect Dis. 2018;4(6):881-892. doi:10.1021/acsinfecdis.8b00030.
AffiliationHIPS, Helmholtz-Institut für Pharmazeutische Forschung Saarland, Universitätscampus E8.1 66123 Saarbrücken, Germany.
PublisherAmerican Chemical Society
JournalACS infectious diseases
The following license files are associated with this item:
- Creative Commons
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-ShareAlike 4.0 International
- Bioinspired and biomimetic systems for advanced drug and gene delivery.
- Authors: Sabu C, Rejo C, Kotta S, Pramod K
- Issue date: 2018 Oct 10
- Bio-inspired, bioengineered and biomimetic drug delivery carriers.
- Authors: Yoo JW, Irvine DJ, Discher DE, Mitragotri S
- Issue date: 2011 Jul 1
- Biomimetic and bioinspired strategies for oral drug delivery.
- Authors: Hu X, Yang G, Chen S, Luo S, Zhang J
- Issue date: 2020 Feb 21
- Bio-inspired engineering of cell- and virus-like nanoparticles for drug delivery.
- Authors: Parodi A, Molinaro R, Sushnitha M, Evangelopoulos M, Martinez JO, Arrighetti N, Corbo C, Tasciotti E
- Issue date: 2017 Dec
- Metal Organic Framework (MOF) Particles as Potential Bacteria-Mimicking Delivery Systems for Infectious Diseases: Characterization and Cellular Internalization in Alveolar Macrophages.
- Authors: Guo A, Durymanov M, Permyakova A, Sene S, Serre C, Reineke J
- Issue date: 2019 Feb 21